As of Wednesday, December 31, Axsome Therapeutics, Inc.’s AXSM share price has surged by 17.93%, which has investors ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in ...

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026NEW YORK, (GLOBE NEWSWIRE) -- ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...

Axsome Therapeutics (AXSM) received formal pre-New Drug Application meeting minutes from the U.S. Food and Drug Administration supporting an NDA ...

Nickelodeon's Tylor Chase has been in touch with former cast mates and members of the media in an effort to connect him with resources amid his state of homelessness ...

Dopamine brings on a surge of pleasure, but too much dopamine in a synapse can ultimately lead to mood disorders and addiction. A recent preclinical study published in The FASEB Journal suggests that ...

Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. was hit with a patent infringement lawsuit on Nov. 14 in New Jersey District Court. The lawsuit, brought by Saul Ewing and Quinn Emanuel Urquhart ...

Summary: A new study shows that estrogen naturally modulates dopamine signaling in the brain, altering how female rats learn reward cues across the reproductive cycle. When estrogen levels were high, ...

A mathematical model reveals circadian rhythms' impact on medication efficacy, particularly for neurological conditions like Parkinson’s disease and depression. The model focuses on dopamine reuptake ...